Nxera Pharma Co Eulerpool News

Nxera Pharma Co Aktie News

Nxera Pharma Co wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Nxera Pharma Co News stellen wir hier zusammen.

• 3. Juni ·

  Yahoo
  Nxera Pharma to Receive US$15 Million from Neurocrine Biosciences Following Dosing of First Patient in Phase 3 Trial of NBI-1117568
• 2. Mai ·

  Yahoo
  Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2025
• 1. Mai ·

  Yahoo
  Nxera Pharma’s Partner Neurocrine Biosciences Initiates Phase 3 Registrational Program of NBI-1117568 as a Potential Treatment for Adults with Schizophrenia
• 28. Februar ·

  Yahoo
  Nxera Pharma Assigns Japan and APAC (ex-China) Rights to Cenerimod for Autoimmune Diseases to Viatris
• 14. Februar ·

  Yahoo
  Nxera Pharma Proposes Changes to its Board of Directors
• 14. Februar ·

  Yahoo
  Nxera Pharma Operational Highlights and Consolidated Results for the Fourth Quarter and Full Year 2024
• 20. Dezember ·

  Yahoo
  Nxera Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
• 19. Dezember ·

  Yahoo
  Nxera Pharma and Shionogi Launch QUVIVIQ™ in Japan for Adults with Insomnia
• 5. November ·

  Yahoo
  Nxera Pharma and Antiverse Enter Collaboration To Design Novel GPCR-Targeted Antibody Therapeutics Using Generative AI
• 1. November ·

  Yahoo
  Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2024